News

The Cap-Score™ is a more sensitive indicator of male fertility across age groups than traditional semen analysis

New study demonstrates the value of using the Cap-Score Test to assess the fertilizing ability in men of all ages…

1 year ago

Trinity Biotech Announces the Appointment of Tom Lindsay to its Board of Directors

DUBLIN, Ireland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic…

1 year ago

Canadian Brain Cancer Patients Treated Unequally: Brain Cancer Canada

TORONTO, Oct. 26, 2022 (GLOBE NEWSWIRE) -- For Canadians diagnosed with brain cancer, where they live determines how much access…

1 year ago

Allogene Therapeutics to Report Third Quarter 2022 Financial Results on November 2, 2022

Conference Call and Webcast Scheduled for 2:00 PM PT/5:00 PM ETSOUTH SAN FRANCISCO, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) --…

1 year ago

Agile Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on Monday, November 7, 2022

Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX),…

1 year ago

Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022

CAMBRIDGE, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine…

1 year ago

Acer Therapeutics Receives Notice of Allowance of Key US Patent Application Covering EDSIVO™ (celiprolol)

Notice of allowance of celiprolol method of treatment of vEDS patent application strengthens proprietary position in U.S. until 2038NEWTON, Mass.,…

1 year ago

Sarepta Therapeutics to Announce Third Quarter 2022 Financial Results

CAMBRIDGE, Mass., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare…

1 year ago

Myovant Sciences Announces Corporate Updates and Financial Results for Second Fiscal Quarter 2022

On October 23, 2022, Sumitovant Biopharma Ltd. (Sumitovant), in conjunction with parent company Sumitomo Pharma Co., Ltd. (Sumitomo Pharma), and…

1 year ago

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ MOU with Rain Cage Carbon to Develop Fullerene-Based Medical Contrast Agents from Carbon Capture of Hydrocarbon Exhaust Systems

VANCOUVER, British Columbia, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has signed a memorandum of understanding with…

1 year ago